Arkolith/Insider Trading/CMMB/Form 4

Mor George Adi

Chief Executive Officer, DirectorChemomab Therapeutics Ltd. (CMMB) · full profile →Form 4 · filed Jun 1, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$20K
Net Open-Market Flow
-$20K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 29, 2026Sell(P)5K$2.05$10K134K
May 29, 2026Sell(P)5K$2.08$10K139K
May 29, 2026Other(J)32K——32K
May 29, 2026Other(J)19K——19K

Transaction Codes

P
Open-market purchase
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001178913-26-003004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML